NCT07438379

Brief Summary

Somaliland faces persistently high burdens of maternal and perinatal mortality, with limited population-based data on pregnancy complications, sociocultural influence on maternal health, and women's reproductive health needs across the continuum of pregnancy, childbirth, and postpartum. Existing maternal near-miss (MNM) tools are largely facility-based, and evidence of postpartum contraceptive uptake and interventions remains scarce. In response, the objective of this study is to unfold the physical, cultural, and psychosocial strengths and challenges experienced by women in Somaliland during pregnancy, childbirth, and the postpartum period; to examine how these factors interact to influence pregnancy outcomes and women's ability to achieve future reproductive health goals; and to pilot how these insights can inform the co-creation of context-appropriate health materials. The PROMISE study is a community-based longitudinal pregnancy cohort in Hargeisa, Somaliland, including approximately 800 pregnant women \<28 weeks of gestation recruited from randomly selected sub-districts. Women will be followed up at three time points (early pregnancy, late pregnancy, and postpartum) using questionnaires and clinical measurements. A MNM tool will be adapted through a Delphi process, and its validity will be tested using the cohort. The cohort findings will inform a co-creation process to develop postpartum contraceptive counselling materials to be pilot-tested for feasibility, acceptability, and preliminary effects. This protocol responds to major evidence gaps in fragile and low-resource contexts, and aims to generate contextually grounded knowledge and co-created interventions to strengthen maternal health policy, practice, and reproductive agency in Somaliland and beyond.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
808

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2025

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2025

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

February 15, 2026

Completed
12 days until next milestone

First Posted

Study publicly available on registry

February 27, 2026

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2026

Completed
Last Updated

February 27, 2026

Status Verified

February 1, 2026

Enrollment Period

1.2 years

First QC Date

February 15, 2026

Last Update Submit

February 22, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Adverse birth outcomes

    A composite of admission to neonatal intensive care unit, mode of birth (vaginal birth, assisted vaginal birth, and cesarean section), postpartum hemorrhage \> 1000 ml, eclampsia, maternal death, stillbirth in 3rd trimester, neonatal death within one and seven days, preterm birth \< week 37, and low birth weight \< 2000 grams.

    Assessed 1 to 3 months post partum

Secondary Outcomes (10)

  • Antenatal care visits

    Assessed between gestational age 36 and birth as well as between 1 to 3 months postpartum

  • Proportion of pregnant women with hypertensive disorders of pregnancy (HDP)

    Assessed between gestational age 36 and birth as well as between 1 to 3 months postpartum

  • Proportion of pregnant women with Gestational Diabetes

    Assessed between gestational age 36 and birth as well as between 1 to 3 months postpartum

  • Postpartum depression

    One to three months postpartum

  • Social support

    Assessed between gestational age 36 and birth

  • +5 more secondary outcomes

Eligibility Criteria

Sexfemale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All pregnant women residing in randomly selected subdistricts of Hargeisa, Somaliland.

You may qualify if:

  • Pregnant woman
  • Gestational age less than 28 weeks at the time of recruitment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Hargeisa

Hargeisa, Maroodijeeh, +252, Somalia

Location

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
12 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

February 15, 2026

First Posted

February 27, 2026

Study Start

January 1, 2025

Primary Completion

March 31, 2026

Study Completion

March 31, 2026

Last Updated

February 27, 2026

Record last verified: 2026-02

Locations